| Time‐Dose‐Response Models for Microbial Risk Assessment Y Huang, CN Haas Risk Analysis 29 (5), 648-661, 2009 | 51 | 2009 |
| Development and validation of a treatment benefit index to identify hospitalized patients with COVID-19 who may benefit from convalescent plasma H Park, T Tarpey, M Liu, K Goldfeld, Y Wu, D Wu, Y Li, J Zhang, ... JAMA network open 5 (1), e2147375-e2147375, 2022 | 34 | 2022 |
| Animal and Human Dose‐Response Models for Brucella Species SS Teske, Y Huang, SB Tamrakar, TA Bartrand, MH Weir, CN Haas Risk Analysis 31 (10), 1576-1596, 2011 | 34 | 2011 |
| Incorporating time postinoculation into a dose–response model of Yersinia pestis in mice Y Huang, TA Bartrand, CN Haas, MH Weir Journal of applied microbiology 107 (3), 727-735, 2009 | 30 | 2009 |
| Prioritizing risks and uncertainties from intentional release of selected Category A pathogens T Hong, PL Gurian, Y Huang, CN Haas PloS one 7 (3), 2012 | 23 | 2012 |
| Dose–response time modelling for highly pathogenic avian influenza A (H5N1) virus infection M Kitajima, Y Huang, T Watanabe, H Katayama, CN Haas Letters in applied microbiology 53 (4), 438-444, 2011 | 20 | 2011 |
| Quantification of the relationship between bacterial kinetics and host response for monkeys exposed to aerosolized Francisella tularensis Y Huang, CN Haas Applied and environmental microbiology 77 (2), 485-490, 2011 | 16 | 2011 |
| How sensitive is safe? Risk-based targets for ambient monitoring of pathogens Y Huang, T Hong, TA Bartrand, PL Gurian, CN Haas, R Liu, SB Tamrakar IEEE Sensors Journal 10 (3), 668-673, 2010 | 13 | 2010 |
| Geographic exposure risk of variant Creutzfeldt‐Jakob disease in US blood donors: a risk‐ranking model to evaluate alternative donor‐deferral policies H Yang, Y Huang, L Gregori, DM Asher, T Bui, RA Forshee, SA Anderson Transfusion 57 (4), 924-932, 2017 | 11 | 2017 |
| Early administration of COVID‐19 convalescent plasma with high titer antibody content by live viral neutralization assay is associated with modest clinical efficacy A Belov, Y Huang, CH Villa, BI Whitaker, R Forshee, SA Anderson, A Eder, ... American Journal of Hematology 97 (6), 770-779, 2022 | 10 | 2022 |
| A modified dose–response model that describes the relationship between haemagglutination inhibition titre and protection against influenza infection Y Huang, SA Anderson, RA Forshee, H Yang Journal of applied microbiology 124 (1), 294-301, 2018 | 8 | 2018 |
| Dose‐Response Models Incorporating Aerosol Size Dependency for Francisella tularensis SS Teske, MH Weir, TA Bartrand, Y Huang, SB Tamrakar, CN Haas Risk Analysis 34 (5), 911-928, 2014 | 8 | 2014 |
| Development of Dose-Response Models of Creutzfeldt-Jakob Disease Infection in Nonhuman Primates for Assessing the Risk of Transfusion-Transmitted Variant Creutzfeldt-Jakob Disease Y Huang, L Gregori, SA Anderson, DM Asher, H Yang Journal of virology 88 (23), 13732-13736, 2014 | 6 | 2014 |
| Dose-response model of murine typhus (Rickettsia typhi): time post inoculation and host age dependency analysis SB Tamrakar, Y Huang, SS Teske, CN Haas BMC infectious diseases 12 (1), 2012 | 5 | 2012 |
| Incorporating time to response into dose-response models used in quantitative microbial risk assessment Y Huang Dissertation Abstracts International 71 (10), 2010 | 4 | 2010 |
| Assessment of risk of variant creutzfeldt‐Jakob disease (vCJD) from use of bovine heparin Y Huang, RA Forshee, D Keire, S Lee, L Gregori, DM Asher, C Bett, ... Pharmacoepidemiology and drug safety 29 (5), 575-581, 2020 | 3 | 2020 |
| Modeling the Dose Response Relationship of Waterborne Acanthamoeba K Dean, S Tamrakar, Y Huang, JB Rose, J Mitchell Risk Analysis 41 (1), 79-91, 2021 | 2 | 2021 |
| A risk assessment model for transfusion transmission of dengue Y Huang, RA Forshee, R Fares‐Gusmao, C Chancey, M Rios, ... Letters in Applied Microbiology 75 (5), 1330-1335, 2022 | 1 | 2022 |
| Modeling US blood donor deferrals under a policy of individual risk assessment for HIV risk sexual behavior BI Whitaker, Y Huang, D Gubernot, AF Eder, D Herbenick, T Fu, ... Transfusion, 2024 | | 2024 |
| Comparison of hemagglutination inhibition and hemagglutinin pseudovirus neutralization titres in relation to protection against influenza in a mouse model Y Huang, Z Lin, W Wang, C Weiss, H Xie, RA Forshee Letters in Applied Microbiology 73 (3), 294-299, 2021 | | 2021 |
